SB0157

Disclosures related to prescription drugs.

Chamber Passed·1/27/26

Indiana SB0157 requires health plans to disclose the national average drug acquisition cost for generic drugs to plan sponsors and covered.

Indiana SB0157 amends the Indiana Code to mandate that health plans provide the national average drug acquisition cost for generic drugs to both the plan sponsor and the covered individual at the point of sale. This disclosure requirement applies to generic drugs covered under a health plan after December 31, 2025, with further amendments applying after December 31, 2026. The bill defines "covered individual" as someone entitled to coverage under a health plan.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Last
Passed the Senate · 44–0 · Jan 27
Current
Public Health Committee
Next
House floor vote

Sponsors

DD
2
4
RRRR
Democratic CaucusRepublican Caucus

Roll Call Votes

Senate - Third reading

44 Yea

RDRRRRRRRDRRRDRRDRRRRRRRRDRRRRRRDRRRRRDRRRRR

0 Nay

5 Absent

RDDDR

Calendar

Jan 14

9:30 AM

Senate Insurance and Financial Institutions Hearing

History

Jan 28

House

First reading: referred to Committee on Public Health

Jan 27

Senate

Referred to the House

Jan 26

Senate

Third reading: passed; Roll Call 72: yeas 44, nays 0